 |
The Journal of Neuroscience, January 9, 2008, 28(2):483-490; doi:10.1523/JNEUROSCI.4067-07.2008
Previous Article | Next Article 
Neurobiology of Disease
Wild-Type But Not FAD Mutant Presenilin-1 Prevents Neuronal Degeneration by Promoting Phosphatidylinositol 3-Kinase Neuroprotective Signaling
Lia Baki,1
Rachael L. Neve,2
Zhiping Shao,1
Junichi Shioi,1
Anastasios Georgakopoulos,1 and
Nikolaos K Robakis1
1Department of Psychiatry and Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York, New York 10029, and 2Department of Psychiatry and Genetics, McLean Hospital, Harvard University, Belmont, Massachusetts 02478-9106
Correspondence should be addressed to either Lia Baki or Nikolaos K. Robakis, Department of Psychiatry, Mount Sinai School of Medicine, New York University, 1 Gustave Levy Place, Box 1229, New York, NY 10029. Email: lia.baki{at}mssm.edu or Email: nikos.robakis{at}mssm.edu
The role of presenilin-1 (PS1) in neuronal phosphatidylinositol 3-kinase (PI3K)/Akt signaling was investigated in primary neuronal cultures from wild-type (WT) and PS1 null (PS1–/–) embryonic mouse brains. Here we show that in PS1–/– cultures, the onset of neuronal maturation coincides with a decrease in the PI3K-dependent phosphorylation-activation of Akt and phosphorylation-inactivation of glycogen synthase kinase-3 (GSK-3). Mature PS1–/– neurons show increased activation of apoptotic caspase-3 and progressive degeneration preceded by dendritic retraction. Expression of exogenous WT PS1 or constitutively active Akt in PS1–/– neurons stimulates PI3K signaling and suppresses both caspase-3 activity and dendrite retraction. The survival effects of PS1 are sensitive to inhibitors of PI3K kinase but insensitive to -secretase inhibitors. Familial Alzheimer disease (FAD) mutations suppress the ability of PS1 to promote PI3K/AKT signaling, prevent phosphorylation/inactivation of GSK-3 and promote activation of caspase-3. These mutation effects are reversed upon coexpression of constitutively active Akt. Together, our data indicate that the neuroprotective role of PS1 depends on its ability to activate the PI3K/Akt signaling pathway and that PS1 FAD mutations increase GSK-3 activity and promote neuronal apoptosis by inhibiting the function of PS1 in this pathway. These observations suggest that stimulation of PI3K/Akt signaling may be beneficial to FAD patients.
Key words: Alzheimer's disease; apoptosis; neuronal death; Akt; phosphorylation; signaling
Received Sept. 5, 2007;
revised Oct. 21, 2007;
accepted Nov. 30, 2007.
Correspondence should be addressed to either Lia Baki or Nikolaos K. Robakis, Department of Psychiatry, Mount Sinai School of Medicine, New York University, 1 Gustave Levy Place, Box 1229, New York, NY 10029. Email: lia.baki{at}mssm.edu or Email: nikos.robakis{at}mssm.edu
This article has been cited by other articles:

|
 |

|
 |
 
Y. Deng, B. Li, Y. Liu, K. Iqbal, I. Grundke-Iqbal, and C.-X. Gong
Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the Brain: Implication for Alzheimer's Disease
Am. J. Pathol.,
November 1, 2009;
175(5):
2089 - 2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, C. Litterst, A. Georgakopoulos, I. Zaganas, and N. K. Robakis
Peptide EphB2/CTF2 Generated by the {gamma}-Secretase Processing of EphB2 Receptor Promotes Tyrosine Phosphorylation and Cell Surface Localization of N-Methyl-D-aspartate Receptors
J. Biol. Chem.,
October 2, 2009;
284(40):
27220 - 27228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Watanabe, M. J. Smith, E. Heilig, V. Beglopoulos, R. J. Kelleher III, and J. Shen
Indirect Regulation of Presenilins in CREB-mediated Transcription
J. Biol. Chem.,
May 15, 2009;
284(20):
13705 - 13713.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|